Top 8 Paulson & CO INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 27.94% | 1.34M | $719.5M | -3.75%(-52.17K) | $227.23(+123.37%) | 2026-06-30 | |
| PPTA | PERPETUA RESOURCES CORP | 26.07% | 32.35M | $671.5M | +0.00%(+0) | $8.38(+201.31%) | 2026-06-30 | |
| AAMI | ACADIAN ASSET MANAGEMENT INC | 16.23% | 5.84M | $417.9M | -24.54%(-1.90M) | $9.91(+833.50%) | 2026-06-30 | |
| BHC | BAUSCH HEALTH COS INC | 14.02% | 73.26M | $361.2M | +0.00%(+0) | $12.43(-47.61%) | 2026-06-30 | |
| THM | INTERNATIONAL TOWER HILL MIN | 8.07% | 104.49M | $207.9M | +4.93%(+4.91M) | $1.42(+90.97%) | 2026-06-30 | |
| NG | NOVAGOLD RESOURCES INC | 6.31% | 27.24M | $162.6M | +0.00%(+0) | $6.51(+22.01%) | 2026-06-30 | |
| THRY | THRYV HLDGS INC | 1.29% | 8.44M | $33.3M | +0.00%(+0) | $8.82(-75.52%) | 2026-06-30 | |
| GOOGL | ALPHABET INC | 0.07% | 5.0K | $1.8M | new | $177.58(+94.79%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +30.45% | +121.98% | +10.48% | +64.62% |
| Top 20 Holdings Unweighted | +41.13% | +181.13% | +19.07% | +139.38% |
Paulson & CO INC reports $2.58B in US-listed equity holdings across 8 positions in its most recent 13F filing. Its largest disclosed positions are MDGL (27.9%), PPTA (26.1%) and AAMI (16.2%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +121.98% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Paulson & CO INC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Paulson & CO INC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1035674). View Paulson & CO INC’s 13F filings on SEC